Financial & competing interests disclosure.
IM Ghobrial serves as an advisory board member for Onyx, Millennium, Bristol Myers Squibb, Celgene and Novartis. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.